AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
STATISTICAL CONSIDERATIONS IN THE DESIGN, CONDUCT AND ANALYSES OF ANTIEMETIC CLINICAL-TRIALS - AN EMERGING CONSENSUS
Authors: MORROW GR BALLATORI E GROSHEN S OLVER I
Citation: Gr. Morrow et al., STATISTICAL CONSIDERATIONS IN THE DESIGN, CONDUCT AND ANALYSES OF ANTIEMETIC CLINICAL-TRIALS - AN EMERGING CONSENSUS, Supportive care in cancer, 6(3), 1998, pp. 261-265
PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE
Authors: ROILA F DELFAVERO A GRALLA RJ TONATO M AAPRO MS ANDREWS PLR BALLATORI E DEMULDER PHM DICATO MA DUBOIS A FEYER PC GANDARA DR GRALLA RJ GRALLA RJ GROSHEN S GRUNBERG SM HERRSTEDT J HESKETH PJ JOSS RA KRIS MG MARTY MM MORROW GR NAYLOR RJ OLVER IN SMYTH JF SPITZER TR STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M DELFAVERO A CICCARESE G BASURTO C CICCARESE G PALLADINO MA PORROZZI S PICCIAFUOCO M CONTU A OLMEO N PAZZOLA A PILO L TATEO S CHIAPPARINI I MORANA S LUCCHINO S RICCI S ANTONUZZO A ALLEGRINI G GALLI L CONTE PF MASSIDDA B IONTA MT SCANU A MURRU R PICECE V CIRILLO M MAGAROTTO R NUZZO A LAUDADIO L SABLONE MG LOCATELLI MC DANTONA A LUPORINI G SCAGLIOTTI G SELVAGGI G MATTEI A FAVALLI G GAMBINO A FAVA S GRIMI E SCARFONE G BOLIS MC ALESSANDRONI P CATALANO G BONI C MORETTI G CORTESI E MARTELLI O ANTIMI M BELLINI V BUZZI E BRUGIA M GRECCHI M CLERICO M MONTINARI F DONATI D SANSONI E
Citation: F. Roila et al., DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS, Journal of clinical oncology, 16(9), 1998, pp. 2937-2942
CLINICAL BENEFIT AS A PRIMARY EFFICACY END-POINT
Authors: BALLATORI E DELFAVERO A ROILA F
Citation: E. Ballatori et al., CLINICAL BENEFIT AS A PRIMARY EFFICACY END-POINT, Journal of clinical oncology, 16(2), 1998, pp. 803-804
5-HT3 RECEPTOR ANTAGONISTS - DIFFERENCES AND SIMILARITIES
Authors: ROILA F BALLATORI E TONATO M DELFAVERO A
Citation: F. Roila et al., 5-HT3 RECEPTOR ANTAGONISTS - DIFFERENCES AND SIMILARITIES, European journal of cancer, 33(9), 1997, pp. 1364-1370
DRUG UTILIZATION FOR PREVENTION OF CHEMOTHERAPY (CT)-INDUCED EMESIS
Authors: ROILA F BALLATORI E PALMIOTTI G EPIFANI C ANTIMI M CATALANO G CRUCIANI G AMICI S TONATO M
Citation: F. Roila et al., DRUG UTILIZATION FOR PREVENTION OF CHEMOTHERAPY (CT)-INDUCED EMESIS, European journal of cancer, 33, 1997, pp. 69-69
CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS
Authors: BALLATORI E ROILA F DEANGELIS V CICCARESE G PALLADINO MA TONATO M DELFAVERO A HERRSTEDT J DICATO M DUBOIS A HESKETH P KRIS M GRALLA RJ
Citation: E. Ballatori et al., CLINICAL AND METHODOLOGICAL ISSUES IN ANTIEMETIC THERAPY - A WORLDWIDE SURVEY OF EXPERTS OPINIONS, Supportive care in cancer, 5(4), 1997, pp. 269-273
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
THE CONTROL OF DELAYED NAUSEA
Authors: ROILA F BALLATORI E
Citation: F. Roila et E. Ballatori, THE CONTROL OF DELAYED NAUSEA, Annals of oncology, 8(6), 1997, pp. 615-615
END-POINTS OF CLINICAL-TRIALS IN ONCOLOGY
Authors: ROILA F DELFAVERO A BALLATORI E
Citation: F. Roila et al., END-POINTS OF CLINICAL-TRIALS IN ONCOLOGY, Tumori, 83(6), 1997, pp. 8-13
ASSESSING QUALITY-OF-LIFE IN ONCOLOGY - R ATIONALE AND OBJECTIVES OF THE FIRST-PHASE OF THE QVONC PROJECT
Authors: COSTANTINI M MENCAGLIA E DIGIULIO P CORTESI E ROILA F BALLATORI E TAMBURINI M CASALI P LICITRA L MASSIDDA B LUZZANI M CAMPORA E DEPLACIDO S PALMERI S PALLADINO MA BARACCO G GARERI R MARTIGNETTI A RAGOSA S ZODA L IONTA MT BULLETTI S PASTORE L
Citation: M. Costantini et al., ASSESSING QUALITY-OF-LIFE IN ONCOLOGY - R ATIONALE AND OBJECTIVES OF THE FIRST-PHASE OF THE QVONC PROJECT, Tumori, 83(2), 1997, pp. 25-27
COMPARATIVE-STUDIES OF VARIOUS ANTIEMETIC REGIMENS
Authors: ROILA F TONATO M BALLATORI E DELFAVERO A
Citation: F. Roila et al., COMPARATIVE-STUDIES OF VARIOUS ANTIEMETIC REGIMENS, Supportive care in cancer, 4(4), 1996, pp. 270-280
METHODOLOGY OF TRIALS WITH ANTIEMETICS
Authors: TONATO M ROILA F DELFAVERO A BALLATORI E
Citation: M. Tonato et al., METHODOLOGY OF TRIALS WITH ANTIEMETICS, Supportive care in cancer, 4(4), 1996, pp. 281-286
A TRIAL TO EVALUATE THE EFFICACY OF PICOTAMIDE IN PREVENTING THROMBOTIC OCCLUSION OF THE VASCULAR ACCESS IN HEMODIALYSIS-PATIENTS
Authors: MILETI M DEPETRI G BACCHI M OGLIARI V PECCHINI F BUFANO G SURIAN M BONFORTE G DOZIO B GILLI P DEPAOLI E USBERTI M GAZZOTTI M BARONI C FERRARI G GRASSI C BRONZIERI C ORAZI S LUSVARGHI E VANDELLI L REDAELLI B VIGANO M MASCIA M BUONCRISTIANI U GABURRI E BRUGNANO R BORGATTI P LINDNER G GASTALDI L NENCI GG GRESELE P VERMYLEN J CAMBI V DEGAETANO G DELFAVERO A FITZGERALD G BALLATORI E CANDELISE L BOSCHETTI E SANTUCCI A BORGNINO C FIORELLA G MILANI M BALESTRI M CAVALHEIRO V GOLA M MACCARI D SELLI ML MIGLIACCI R
Citation: M. Mileti et al., A TRIAL TO EVALUATE THE EFFICACY OF PICOTAMIDE IN PREVENTING THROMBOTIC OCCLUSION OF THE VASCULAR ACCESS IN HEMODIALYSIS-PATIENTS, JN. Journal of nephrology, 8(3), 1995, pp. 167-172
ONDANSETRON VS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
Authors: ROILA F DEANGELIS V MORETTI G TATEO S CASCINU S IONTA MT MONTINARI F MORRITTI M PUSCEDDU G FAVALLI G CORTESI E DAZZI C BALLATORI E
Citation: F. Roila et al., ONDANSETRON VS GRANISETRON, BOTH COMBINED WITH DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS, European journal of cancer, 31A, 1995, pp. 1226-1226
CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: CRINO L CLERICI M FIGOLI F CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E DARWISH S SCARCELLA L SANTUCCI A BALLATORI E
Citation: L. Crino et al., CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), Annals of oncology, 6(4), 1995, pp. 347-353
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: CRINO L CLERICI M FIGOLI F BARDUAGNI M CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E SANTUCCI A BALLATORI E TONATO M
Citation: L. Crino et al., SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, Lung cancer, 12, 1995, pp. 125-132
ANTIEMETIC PROPERTIES OF GRANISETRON - REPLY
Authors: ROILA F BALLATORI E DELFAVERO A
Citation: F. Roila et al., ANTIEMETIC PROPERTIES OF GRANISETRON - REPLY, The New England journal of medicine, 332(24), 1995, pp. 1653-1654
DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M RIVA E PANZA MT DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S ROSSO R COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M DEPENNI R SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S MUTTINI MP CONTE PF SALVATI F NUNZIATI F SIGNORA M CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E TRINCA C LUPORINI G LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: F. Roila et al., DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER, The New England journal of medicine, 332(1), 1995, pp. 1-5
MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS
Authors: FALINI B VENTURI S MARTELLI M SANTUCCI A PILERI S PESCARMONA E GIOVANNINI M MAZZA P MARTELLI MF PASQUALUCCI L BALLATORI E GUGLIELMI C AMADORI S POGGI S SABATTINI E GHERLINZONI F ZINZANI PL BARONI CD MANDELLI F TURA S
Citation: B. Falini et al., MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS, British Journal of Haematology, 89(4), 1995, pp. 780-789
COST AND COST-EFFECTIVENESS ANALYSIS OF ONDANSETRON VERSUS METOCLOPRAMIDE REGIMENS - A HOSPITAL PERSPECTIVE FROM ITALY
Authors: BALLATORI E ROILA F BERTO P DEANGELIS V NERI C OLIVIERI A TONATO M DELFAVERO A
Citation: E. Ballatori et al., COST AND COST-EFFECTIVENESS ANALYSIS OF ONDANSETRON VERSUS METOCLOPRAMIDE REGIMENS - A HOSPITAL PERSPECTIVE FROM ITALY, PharmacoEconomics, 5(3), 1994, pp. 227-237
ANTIEMETICS IN CANCER-CHEMOTHERAPY - HISTORICAL-PERSPECTIVE AND CURRENT STATE-OF-THE-ART
Authors: TONATO M ROILA F DELFAVERO A BALLATORI E
Citation: M. Tonato et al., ANTIEMETICS IN CANCER-CHEMOTHERAPY - HISTORICAL-PERSPECTIVE AND CURRENT STATE-OF-THE-ART, Supportive care in cancer, 2(3), 1994, pp. 150-160
ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER
Authors: FAVALLI G ROILA F TONATO M DEANGELIS V BALLATORI E DELFAVERO A BASURTO C CORGNA E PALLADINO MA PICCIAFUOCO M CICCARESE G PATOIA L GARBELLI R BIANCHI UA SCARFONE G FERRARIS C BOLIS MC COGNETTI F COLELLA E BUZZI F DELRIO S SABBATINI R SILINGARDI V MATERA G CELLERINO R DAZZI C MARANGOLO M LEONARDI M CANALETTI R BABILONTI L ZARA C DONATI D AMADORI D FERRARI M
Citation: G. Favalli et al., ONDANSETRON PLUS DEXAMETHASONE VERSUS METOCLOPRAMIDE PLUS DEXAMETHASONE PLUS DIPHENHYDRAMINE IN CISPLATIN-TREATED PATIENTS WITH OVARIAN-CANCER, Supportive care in cancer, 2(3), 1994, pp. 167-170
Risultati: 1-25 | 26-30